Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) A multicenter retrospective nationwide Italian study and crowdsourcing opportunity

Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be poorly transferrable to clinical practice. Thus, evidence from studies using routinely accumulated clinical data are increasingly valued. We herein describe rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes), a multicenter retrospective nationwide study conducted at 50 specialist outpatient clinics in Italy and promoted by the Italian Diabetes Society.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - August 7, 2017 Category: Nutrition Authors: Gian Paolo Fadini, Giancarlo Zatti, Agostino Consoli, Enzo Bonora, Giorgio Sesti, Angelo Avogaro, DARWIN-T2D network Source Type: research